Ozmosi | Pyritinol Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

Pyritinol

Alternative Names: pyritinol
Clinical Status: Inactive
Latest Update: 2018-02-28
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Vitamin B6 Analogue

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Chile | China | Colombia | Dominican Republic | Ecuador | Germany | Hong Kong | India | Indonesia | Ireland | Italy | Jordan | Mexico | Pakistan | Peru | Portugal | Romania | Russia | Turkey | Venezuela

Approved Indications: None

Company: Hannover Medical School
Company Location:
Company Founding Year: None
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 3: Schizophrenia|Tic Disorders|Depressive Disorder|Dementia|Psychophysiologic Disorders

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

NCT02374567

GAP

P3

Terminated

Tic Disorders|Schizophrenia|Psychophysiologic Disorders|Dementia|Depressive Disorder

2017-06-28

2024-10-16

Primary Endpoints|Treatments

Recent News Events

Date

Type

Title